Literature DB >> 26861154

Reported associations between asthma and acute lymphoblastic leukemia: insights from a hybrid simulation study.

Madhuri Sudan1, Onyebuchi A Arah2, Jorn Olsen3, Leeka Kheifets2.   

Abstract

Numerous studies have reported a protective association between asthma and acute lymphoblastic leukemia (ALL), but the causal structure of this association remains unclear. We present a hybrid simulation to examine the compatibility of this association with uncontrolled confounding by infection or another unmeasured factor. We generated a synthetic cohort using inputs on the interrelations of asthma, ALL, infections, and other suggested risk factors from the literature and the Danish National Birth Cohort. We computed odds ratios (ORs) between asthma and ALL in the synthetic cohort with and without adjustment for infections and other (including unmeasured) confounders. Only if infection was an extremely strong risk factor for asthma (OR of 10) and an extremely strong protective factor against ALL (OR of 0.1) was the asthma-ALL association compatible with the literature (OR of 0.78). Similarly, strong uncontrolled confounding by an unmeasured factor could downwardly bias the asthma-ALL association, but not enough to replicate findings in the literature. This investigation illustrates that the reported protective association between asthma and ALL is unlikely to be entirely due to uncontrolled confounding by infections or an unmeasured confounder alone. Simulation can be used to advance our understanding of risk factors for rare outcomes as demonstrated by this study.

Entities:  

Keywords:  Asthma; Childhood leukemia; Confounding; Infection; Risk factors; Simulation

Mesh:

Year:  2016        PMID: 26861154     DOI: 10.1007/s10654-016-0126-x

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  69 in total

1.  Allergy and the risk of childhood leukemia: a meta-analysis.

Authors:  S Dahl; L S Schmidt; T Vestergaard; J Schüz; K Schmiegelow
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

2.  Atopic disease and childhood acute lymphoblastic leukemia.

Authors:  Joachim Schüz; Gareth Morgan; Eva Böhler; Peter Kaatsch; Jörg Michaelis
Journal:  Int J Cancer       Date:  2003-06-10       Impact factor: 7.396

3.  Allergy and infectious disease histories and the risk of childhood acute lymphoblastic leukaemia.

Authors:  Paula F Rosenbaum; Germaine M Buck; Martin L Brecher
Journal:  Paediatr Perinat Epidemiol       Date:  2005-03       Impact factor: 3.980

Review 4.  Breast-feeding and childhood cancer: A systematic review with metaanalysis.

Authors:  Richard M Martin; David Gunnell; Christopher G Owen; George Davey Smith
Journal:  Int J Cancer       Date:  2005-12-20       Impact factor: 7.396

5.  Ethnic difference in daycare attendance, early infections, and risk of childhood acute lymphoblastic leukemia.

Authors:  Xiaomei Ma; Patricia A Buffler; Joseph L Wiemels; Steve Selvin; Catherine Metayer; Mignon Loh; Monique B Does; John K Wiencke
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-08       Impact factor: 4.254

6.  Maternal alcohol and coffee drinking, parental smoking and childhood leukaemia: a French population-based case-control study.

Authors:  Florence Menegaux; Mahaut Ripert; Denis Hémon; Jacqueline Clavel
Journal:  Paediatr Perinat Epidemiol       Date:  2007-07       Impact factor: 3.980

7.  Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia.

Authors:  L Spector; F Groves; F DeStefano; J Liff; M Klein; J Mullooly; S Black; H Shinefield; J Ward; M Marcy
Journal:  Eur J Cancer       Date:  2004-03       Impact factor: 9.162

8.  Childhood cancer and parental use of tobacco: deaths from 1971 to 1976.

Authors:  T Sorahan; P Prior; R J Lancashire; S P Faux; M A Hultén; I M Peck; A M Stewart
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Breastfeeding patterns and risk of childhood acute lymphoblastic leukaemia.

Authors:  M L Kwan; P A Buffler; J L Wiemels; C Metayer; S Selvin; J M Ducore; G Block
Journal:  Br J Cancer       Date:  2005-08-08       Impact factor: 7.640

10.  Infections in early life and childhood leukaemia risk: a UK case-control study of general practitioner records.

Authors:  C R Cardwell; P A McKinney; C C Patterson; L J Murray
Journal:  Br J Cancer       Date:  2008-09-30       Impact factor: 7.640

View more
  5 in total

1.  Caution: work in progress : While the methodological "revolution" deserves in-depth study, clinical researchers and senior epidemiologists should not be disenfranchised.

Authors:  Miquel Porta; Francisco Bolúmar
Journal:  Eur J Epidemiol       Date:  2016-07-14       Impact factor: 8.082

2.  The methodological 'revolution': caution accepted.

Authors:  Jørn Olsen; Maduri Sudan; Onyebuchi A Arah; Leeka Kheifets
Journal:  Eur J Epidemiol       Date:  2016-08-30       Impact factor: 8.082

3.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

4.  The sensitivity of reported effects of EMF on childhood leukemia to uncontrolled confounding by residential mobility: a hybrid simulation study and an empirical analysis using CAPS data.

Authors:  Aryana T Amoon; Onyebuchi A Arah; Leeka Kheifets
Journal:  Cancer Causes Control       Date:  2019-05-29       Impact factor: 2.506

5.  Re-examining the association between residential exposure to magnetic fields from power lines and childhood asthma in the Danish National Birth Cohort.

Authors:  Madhuri Sudan; Onyebuchi A Arah; Thomas Becker; Yael Levy; Torben Sigsgaard; Jørn Olsen; Ximena Vergara; Leeka Kheifets
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.